BAM
Blueshift Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,264
| Closed | -$446K | – | 388 |
|
|
2024
Q3 | $446K | Buy |
+2,264
| New | +$446K | 0.11% | 214 |
|
|
2022
Q4 | – | Sell |
-2,155
| Closed | -$424K | – | 401 |
|
|
2022
Q3 | $424K | Buy |
2,155
+278
| +15% | +$54.7K | 0.09% | 316 |
|
|
2022
Q2 | $402K | Buy |
+1,877
| New | +$402K | 0.07% | 372 |
|
|
2022
Q1 | – | Sell |
-1,446
| Closed | -$545K | – | 876 |
|
|
2021
Q4 | $545K | Sell |
1,446
-12,296
| -89% | -$4.63M | 0.05% | 449 |
|
|
2021
Q3 | $5.67M | Buy |
13,742
+10,886
| +381% | +$4.49M | 0.32% | 69 |
|
|
2021
Q2 | $1.06M | Buy |
+2,856
| New | +$1.06M | 0.06% | 341 |
|
|
2021
Q1 | – | Sell |
-3,846
| Closed | -$961K | – | 884 |
|
|
2020
Q4 | $961K | Buy |
+3,846
| New | +$961K | 0.11% | 275 |
|
|
2020
Q3 | – | Sell |
-5,686
| Closed | -$991K | – | 624 |
|
|
2020
Q2 | $991K | Buy |
+5,686
| New | +$991K | 0.16% | 183 |
|
|
2019
Q3 | – | Sell |
-10,088
| Closed | -$1.43M | – | 758 |
|
|
2019
Q2 | $1.43M | Buy |
+10,088
| New | +$1.43M | 0.19% | 170 |
|
|
2019
Q1 | – | Sell |
-14,772
| Closed | -$1.67M | – | 741 |
|
|
2018
Q4 | $1.67M | Buy |
+14,772
| New | +$1.67M | 0.31% | 65 |
|